艾伯维公司 ABBV 深 沪
已收盘 05-08 16:00:00 美东时间
201.55
-1.160
-0.57%
华盛通- 最 高202.40
- 今 开201.92
- 成交量 491.57万股
- 最 低 200.02
- 昨 收 202.71
- 总市值 3564.94亿
- 52周最高 239.71
- 市盈率 静 85.37
- 换手率 0.28%
- 52周最低 173.51
- 委 比 0.00%
- 总股本 17.69亿
- 历史最高 239.71
- 量 比 0.84
- 振 幅 1.17%
- 历史最低 -20.34
- 每 手 1
- 风险率 17.57%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多AbbVie’s New Drug Milestone Fuels Hype Despite Insider Selling
AbbVie ( ($ABBV) ) has been popular among investors this week. Here is a recap ...
05-09 23:03
全球药企研发投入TOP 15榜单揭晓！
默沙东 默沙东持续通过研发与收购扩展研发管线。今年3月，该公司斥资约67亿美元收购了Terns Pharmaceuticals，获得治疗慢性髓系白血病...
05-09 07:31
'Health Officials Close To U.S. Secretary Kennedy Explored Ban Of Some Widely Used Antidepressants' - Reuters Exclusive
Health officials explored restricting specific antidepressants among SSRI drugs-sourcesKennedy announced other steps to reduce use of the medicines on MondayKennedy says SSRIs are overprescribed and, without evidence,
05-09 00:02
AbbVie Completes Early Safety Study for ABBV-142, Nudging Pipeline Hopes Higher
Abbvie ($ABBV) announced an update on their ongoing clinical study. AbbVie (ABB...
05-08 00:30
直播推荐 | 告别体外编辑:体内CAR-T治疗的研发进展与CMC挑战
（来源：抗衰老产业联盟） 2026年4月20日，礼来制药以70 亿美元天价收购体内CAR-T企业Kelonia Therapeutics，预付款 32.5 亿...
05-07 10:28
美股大行评级 | 潜在涨幅85%！SoFi获机构升目标价至49美元；华尔街大行看涨AMD至400美元
今日重点评级关注：Canaccord Genuity：维持Sagimet Biosciences"买入"评级，目标价从28美元升至49美元；HC Wainwright & Co.：维持Fate Therapeutics"买入"评级，目标价从5美元升至7美元
05-05 11:40
Healthpeak Properties Q1 Earnings Preview
Healthpeak Properties (DOC) is scheduled to announce Q1 earnings results on Tuesday, May 5th, after market close. The consensus FFO Estimate is $0.43 and the consensus Revenue Estimate is $693.13M. Mo...
05-05 05:35
FACTBOX-Global pharma companies that have publicly announced Trump drug pricing agreements
FACTBOX-Global pharma companies that have publicly announced Trump drug pricing agreements Changes dateline, updates paragraph 1, adds Regeneron's deal details May 4 (Reuters) - U.S. President Donald Trump secured agreements with 17 major pharmaceutical companies to bring U.S. prescription drug pric
05-04 22:45
FACTBOX-Global drugmakers rush to boost US presence as tariff threat looms
FACTBOX-Global drugmakers rush to boost US presence as tariff threat looms Changes dateline, updates paragraph 1, adds Amgen's investment May 4 (Reuters) - Global drugmakers have been ramping up U.S. manufacturing and stockpiling inventory as the Trump administration moves to impose 100% tariffs on
05-04 21:45
美股大行评级 | 苹果获多家机构上调目标价，最高至335美元；闪迪获华尔街大行看多至2000美元
今日重点评级关注：Benchmark：维持史密斯微软件"买入"评级，目标价从2美元升至2.5美元；Citizens：维持DBV Technologies"跑赢大市"评级，目标价从47美元升至55美元
05-04 16:04
